Intrinsiqq
Optex Systems Holdings Inc. logo

Optex Systems Holdings Inc. Insider Trading

OPXS

⊜ Compare
Last 12 months

Insiders sold $1.61M and bought nothing on the open market.

94% of the selling was scheduled in advance under 10b5-1 plans. CEO and President Chad Michael George sold 96K on Mar 11, 100% of their stake, outside a plan. The last open-market buy by an executive or director was in Sep 2021.

Net open-market
−$1.61M
0 buys · 3 sales
Under a 10b5-1 plan
94%
of the value sold
Insiders who bought / sold
0 / 2
executives and directors
Last open-market buy
Sep 2021
Sep 14, 2021

Get an email when OPXS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Mar 11No plan
    Chad Michael George
    CEO and President · sold 7,035 at $13.62
    96K
    100% of stake
  • Jan 7 – 810b5-1 plan
    Danny Robert Schoening
    Director · sold 56,870 at avg $13.75
    782K
    6.7% of stake
  • Jan 2 – 610b5-1 plan
    Danny Robert Schoening
    Director · sold 53,708 at avg $13.57
    729K
    5.9% of stake
  • Jun 26, 2025 – Jun 30, 2025No plan
    Topline Capital Management, LLC
    Large holder · sold 88,645 at avg $11.42
    $1.01M
    11% of stake
  • Jun 26, 2025 – Jun 30, 2025No plan
    Topline Capital Partners, LP
    Large holder · sold 88,645 at avg $11.42
    $1.01M
    11% of stake
  • Jun 27, 2025No plan
    R. Rimmy Malhotra
    Director · sold 15,000 at $11.01
    165K
    13% of stake
  • Jun 13, 2025 – Jun 17, 2025No plan
    Judd Dayton
    Director · sold 18,377 at avg $9.27
    170K
    2.1% of stake
  • Jun 9, 2025No plan
    R. Rimmy Malhotra
    Director · sold 5,000 at $9.37
    47K
    4.3% of stake
  • Jun 6, 2025No plan
    Karen Lea Hawkins
    CFO · sold 12,000 at $9.21
    111K
    28% of stake
  • Jun 5, 2025 – Jun 6, 2025No plan
    Dale E Lehmann
    Director · sold 25,537 at avg $9.28
    237K
    18% of stake
  • Jun 2, 2025 – Jun 3, 202510b5-1 plan
    Danny Robert Schoening
    President & CEO · sold 20,000 at avg $8.73
    175K
    2.2% of stake
  • May 23, 202510b5-1 plan
    Danny Robert Schoening
    President & CEO · sold 2,186 at $8.07
    18K
    0.2% of stake
  • May 21, 2025 – May 22, 202510b5-1 plan
    Danny Robert Schoening
    President & CEO · sold 19,814 at avg $8.03
    159K
    2.1% of stake
  • Mar 7, 2025No plan
    Dale E Lehmann
    Director · sold 30,000 at $5.65
    170K
    17% of stake
  • Dec 27, 2024 – Dec 30, 2024No plan
    Topline Capital Management, LLC
    Large holder · sold 26,162 at avg $7.13
    187K
    3.2% of stake
  • Dec 27, 2024 – Dec 30, 2024No plan
    Topline Capital Partners, LP
    Large holder · sold 26,162 at avg $7.13
    187K
    3.2% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch OPXS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Optical Instruments & Lenses · Pick stocks to compare with OPXS

CompareIntrinsic value
OPTXSyntec Optics Holdings Inc.
$4.56-9.52%10
MSAIMultisensor AI Holdings Inc.
$3.17-0.31%25
RPIDRapid Micro Biosystems, Inc.
$0.68-1.59%30
SENSSenseonics Holdings, Inc.
$9.02+1.81%40
BNGOBionano Genomics Inc.
$1.19-0.83%33
AEHRAehr Test Systems
$60.84-6.56%13
PRPOPrecipio Inc.
$19.57+5.10%57
BCHTBirchtech Corp.
$1.10-1.79%10

Held by ETFs

OPXS is in 1 US ETF. The largest of them, with OPXS's weight in each:

Spot a number that looks wrong? Check it in OPXS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OPXS

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.